에소테릭 테스트 시장(2026-2030년)

The global esoteric testing market is forecasted to grow by USD 31469.9 mn during 2025-2030, accelerating at a CAGR of 13.3% during the forecast period. The report on the global esoteric testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of rare diseases and complex chronic pathologies, rapid technological evolution in molecular diagnostics and high-throughput sequencing, growing adoption of precision medicine and companion diagnostics in clinical workflows.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global esoteric testing market is segmented as below:

By Type

• Infectious disease
• Endocrinology
• Oncology
• Immunology
• Others

By End-User

• Hospital laboratories
• Clinical research laboratories
• Reference laboratories

By Technology

• Immunoassays
• PCR
• Mass spectrometry
• Flow cytometry
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and machine learning in complex data interpretation as one of the prime reasons driving the global esoteric testing market growth during the next few years. Also, proliferation of multi-omics approaches for holistic biological insights and expansion of decentralized and patient-centric esoteric testing models will lead to sizable demand in the market.

The report on the global esoteric testing market covers the following areas:

• Global esoteric testing market sizing
• Global esoteric testing market forecast
• Global esoteric testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global esoteric testing market vendors that include Agendia Inc., Ambry Genetics, ARUP Laboratories, BioReference Laboratories Inc., Caris Life Sciences Inc., Castle Biosciences Inc., Cerba HealthCare, Eurofins Scientific SE, Exact Sciences Corp., HU Group Holdings Inc., Laboratory Holdings Inc., Mayo Medical Laboratories, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sonic Healthcare Ltd., SYNLAB International GmbH, Tempus AI Inc., Unilabs AB. Also, the global esoteric testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Esoteric Testing Market 2020 - 2024
  • Historic Market Size - Data Table on Global Esoteric Testing Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Esoteric Testing Market
• 6.2 Impact of Geopolitical Conflicts on Global Esoteric Testing Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Infectious disease - Market size and forecast 2025-2030
• 8.4 Endocrinology - Market size and forecast 2025-2030
• 8.5 Oncology - Market size and forecast 2025-2030
• 8.6 Immunology - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospital laboratories - Market size and forecast 2025-2030
• 9.4 Clinical research laboratories - Market size and forecast 2025-2030
• 9.5 Reference laboratories - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Immunoassays - Market size and forecast 2025-2030
• 10.4 PCR - Market size and forecast 2025-2030
• 10.5 Mass spectrometry - Market size and forecast 2025-2030
• 10.6 Flow cytometry - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Chile - Market size and forecast 2025-2030
  • 12.6.8 Egypt - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global prevalence of rare diseases and complex chronic pathologies
  • Rapid technological evolution in molecular diagnostics and high-throughput sequencing
  • Growing adoption of precision medicine and companion diagnostics in clinical workflows
• 13.2 Market challenges
  • High capital investment and operational expenses
  • Navigating complex regulatory frameworks
  • Acute shortage of highly trained laboratory professionals and molecular pathologists
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of AI and machine learning in complex data interpretation
  • Proliferation of multi-omics approaches for holistic biological insights
  • Expansion of decentralized and patient-centric esoteric testing models

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agendia Inc.
  • Agendia Inc. - Overview
  • Agendia Inc. - Product / Service
  • Agendia Inc. - Key offerings
  • SWOT
• 15.5 Ambry Genetics
  • Ambry Genetics - Overview
  • Ambry Genetics - Product / Service
  • Ambry Genetics - Key offerings
  • SWOT
• 15.6 ARUP Laboratories
  • ARUP Laboratories - Overview
  • ARUP Laboratories - Product / Service
  • ARUP Laboratories - Key offerings
  • SWOT
• 15.7 BioReference Laboratories Inc.
  • BioReference Laboratories Inc. - Overview
  • BioReference Laboratories Inc. - Product / Service
  • BioReference Laboratories Inc. - Key offerings
  • SWOT
• 15.8 Cerba HealthCare
  • Cerba HealthCare - Overview
  • Cerba HealthCare - Product / Service
  • Cerba HealthCare - Key offerings
  • SWOT
• 15.9 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
  • SWOT
• 15.10 HU Group Holdings Inc.
  • HU Group Holdings Inc. - Overview
  • HU Group Holdings Inc. - Product / Service
  • HU Group Holdings Inc. - Key offerings
  • SWOT
• 15.11 Laboratory Holdings Inc.
  • Laboratory Holdings Inc. - Overview
  • Laboratory Holdings Inc. - Business segments
  • Laboratory Holdings Inc. - Key offerings
  • Laboratory Holdings Inc. - Segment focus
  • SWOT
• 15.12 Mayo Medical Laboratories
  • Mayo Medical Laboratories - Overview
  • Mayo Medical Laboratories - Product / Service
  • Mayo Medical Laboratories - Key offerings
  • SWOT
• 15.13 Myriad Genetics Inc.
  • Myriad Genetics Inc. - Overview
  • Myriad Genetics Inc. - Product / Service
  • Myriad Genetics Inc. - Key offerings
  • SWOT
• 15.14 Quest Diagnostics Inc.
  • Quest Diagnostics Inc. - Overview
  • Quest Diagnostics Inc. - Business segments
  • Quest Diagnostics Inc. - Key offerings
  • Quest Diagnostics Inc. - Segment focus
  • SWOT
• 15.15 Sonic Healthcare Ltd.
  • Sonic Healthcare Ltd. - Overview
  • Sonic Healthcare Ltd. - Business segments
  • Sonic Healthcare Ltd. - Key offerings
  • Sonic Healthcare Ltd. - Segment focus
  • SWOT
• 15.16 SYNLAB International GmbH
  • SYNLAB International GmbH - Overview
  • SYNLAB International GmbH - Product / Service
  • SYNLAB International GmbH - Key offerings
  • SWOT
• 15.17 Tempus AI Inc.
  • Tempus AI Inc. - Overview
  • Tempus AI Inc. - Product / Service
  • Tempus AI Inc. - Key offerings
  • SWOT
• 15.18 Unilabs AB
  • Unilabs AB - Overview
  • Unilabs AB - Product / Service
  • Unilabs AB - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations